Results 211 to 220 of about 130,425 (315)
Activating KRAS Mutations Expressed in 3D Endothelial Spheroids Induce Blebbing Morphologies Associated with Amoeboid-like Migration. [PDF]
McRobb LS, Lee VS, Stoodley MA.
europepmc +1 more source
Abstract Objective Early detection of ovarian cancer at stage I is important to improve patients‘ prognosis. The goal of this study was to examine if transvaginal ultrasound (TVU) performed at the same time as cervical cancer screening can facilitate early detection of ovarian cancer.
Hiromasa Fujita +5 more
wiley +1 more source
KRAS<sup>G12D</sup> mutation promotes pancreatic tumorigenesis by suppressing sirtuin three via the guanine nucleotide exchange factor RCC1. [PDF]
Mai T +7 more
europepmc +1 more source
We assembled National Cancer Center–Clinical Diagnostics Knowledgebase, a clinical genomic knowledgebase of 6935 tumors with matched normal samples, revealing key somatic alterations and actionable variants (70.2% of the cohort). Enrichment of certain different gene mutations was observed between Chinese and American populations, along with a strong ...
Hongrui Li +10 more
wiley +1 more source
Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer. [PDF]
Zhu L +7 more
europepmc +1 more source
RNA‐based fusion panels using targeted next‐generation sequencing of formalin‐fixed paraffin‐embedded (FFPE) tumour tissue specimens have been used for a few years from patients with various tumour types to detect rearrangements/fusions. Using the bioinformatic approaches the data obtained from RNA sequencing (RNAseq) can also be used for small ...
Pranav Dorwal +14 more
wiley +1 more source
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges. [PDF]
Choucair K +8 more
europepmc +1 more source
The current understanding of KRAS oligomerization on membranes
Nastazia Lesgidou +6 more
openalex +1 more source
ABSTRACT This study investigated the impact of pretreatment nutritional status, psychological health, fatigue, and insomnia on outcomes of immune checkpoint inhibitors (ICIs) monotherapy in patients with advanced non‐small cell lung cancer (NSCLC). A total of 80 patients with stage IV NSCLC were enrolled.
Yu‐Xuan Zhu +2 more
wiley +1 more source

